About Anthony Zook
Anthony Zook is a chief executive officer and director at Neogenomics.
Form D filings name Anthony Zook as a director at Algorithm Sciences and Voltron Therapeutics.
Anthony Zook reports to the SEC as a director or officer of 5 public companies, including Adaptin Bio, Streamex (STEX) and Innocoll Holdings plc (INNL).
Anthony Zook first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony Zook in the role, so the role may have started earlier or lasted longer.
NI
Neogenomics Inc.
Chief Executive Officer and director
2023 – 2026 · Public company (NEO)
AI
Adaptin Bio, Inc.
Director
2025 · Public company
SC
Streamex Corp.
Director
2020 – 2022 · Public company (STEX)
IP
Innocoll Holdings plc
CEO and director
2017 · Public company (INNL)
VI
Vivus Inc.
Chief Executive Officer and director
2013 · Public company (VVUS)
Key Colleagues at Startups
The people Anthony Zook works with at each company, as listed on that company's latest Form D.
Algorithm Sciences, Inc. · Form D, Apr 12, 2024
MT
Michael Tilton
Chief Executive Officer and director
DC
David Cavalier
Chief Financial Officer and Chief Operating Officer
KM
Kamal Mubark
Director
JA
James Ahern
Director
MD
Matthew Duffy
Director
JD
Jeffrey O'Donnell
Director
GG
Gary Gemignani
Director
PG
Patrick Gallagher
Director
Voltron Therapeutics, Inc. · Form D/A, Nov 9, 2023
ME
Matthew Eitner
Director
PK
Paul Korner
Director
JA
James Ahern
Director
MD
Matthew Duffy
President and director
PG
Patrick Gallagher
Chief Executive Officer and director